Grown Rogue International (GRUSF) Cash & Current Investments (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Cash & Current Investments of $13.7 million in Q1 2026, up 20.48% quarter-over-quarter from $11.4 million in Q4 2025, and up 146.3% on a YoY basis from $5.6 million in Q1 2025.
Grown Rogue International (GRUSF) Cash & Current Investments (2009 - 2026) Analysis & Trends
Grown Rogue International's Cash & Current Investments history runs 18 years deep, the most recent figure standing at $13.7 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 146.3% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $13.7 million (up 146.3% YoY), while the FY2025 annual figure was $11.4 million, up 133.46% from the prior year.
- Cash & Current Investments was $13.7 million for Q1 2026 at Grown Rogue International, up from $11.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $10359.4 billion in Q3 2025 to a low of $0.84 in Q4 2022.
- Historically, Cash & Current Investments has averaged $951.0 billion across 5 years, with a median of $4.5 million in 2024.
- Biggest YoY gain for Cash & Current Investments was 252729351.53% in 2025; the steepest drop was 100.0% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $0.84 in 2022, then surged by 775760783.71% to $6.5 million in 2023, then jumped by 74627599.05% to $4855.8 billion in 2024, then slumped by 100.0% to $11.4 million in 2025, then gained by 20.48% to $13.7 million in 2026.
- The last three Cash & Current Investments figures came in at $13.7 million (Q1 2026), $11.4 million (Q4 2025), and $10359.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 13.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.70 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 10,359.45 Bn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Dec 31, 2024 | 4,855.80 Bn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 9.45 Mn |
| Dec 31, 2023 | 6.51 Mn |
| Oct 31, 2023 | 1.17 Mn |
| Apr 30, 2023 | 1.58 Mn |
| Jan 31, 2023 | 3.49 Mn |
| Oct 31, 2022 | 0.84 |
| Apr 30, 2022 | 1.11 Mn |
| Jan 31, 2022 | 1.11 Mn |
| Oct 31, 2021 | 173,236.80 |
| Jul 31, 2021 | 177.28 Bn |
| Apr 30, 2021 | 217,788.00 |
| Jan 31, 2021 | 217,788.00 |